CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY

Sixteen female patients with diabetes-associated osteoarthritis (DAOA) participated in an openlabel, randomized, cross-over study. The mean patients’ age was 65.5 (±5.4) years, the patients were obese (mean body mass index, 35.8±5.7 kg/m2 ). They suffered from durable osteoarthritis (14.5±7.6 years)...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: V. S. Shirinsky, E. V. Kazygasheva, N. Yu. Kalynovskaya, I. V. Shirinsky
Format: Artigo
Sprog:Russo
Udgivet: SPb RAACI 2017-05-01
Serier:Medicinskaâ Immunologiâ
Fag:
osteoarthritis
comorbidity
type 2 diabetes
peroxisome proliferator-activated receptors α
lipids
cytokines
inflammation
Online adgang:https://www.mimmun.ru/mimmun/article/view/1219
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker